alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 74, Number 40 (Tuesday, March 3, 2009)]
[Notices]
[Pages 9253-9254]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-4411]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Microbiology, Infectious Diseases and AIDS 
Initial Review Group; Acquired Immunodeficiency Syndrome Research 
Review Committee.
    Date: March 30-31, 2009.
    Time: 8 a.m. to 12 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington/Rockville, 1750 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Erica L. Brown, PhD, Scientific Review Officer, 
Scientific Review Program, Division of Extramural Activities, 
National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 
7616, Bethesda, MD 20892-7616, 301-451-2639, <a href="/cdn-cgi/l/email-protection#0b6e6979647c654b65626a626f25656263256c647d"><span class="__cf_email__" data-cfemail="cbaea9b9a4bca58ba5a2aaa2afe5a5a2a3e5aca4bd">[email protected]</span></a>.
    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Pandemic Flu.
    Date: April 1, 2009.

[[Page 9254]]

    Time: 9 a.m. to 12 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6700B Rockledge Drive, 
Bethesda, MD 20817, (Telephone Conference Call).
    Contact Person: Clayton C. Huntley, PhD, Scientific Review 
Officer, Scientific Review Program, National Institutes of Health/
NIAID, Room 3124, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 
20892-7616, 301-451-2570, <a href="/cdn-cgi/l/email-protection#600308150e140c0519200e090109044e0e09084e070f16"><span class="__cf_email__" data-cfemail="3f5c574a514b535a467f51565e565b1151565711585049">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, 
Immunology, and Transplantation Research; 93.856, Microbiology and 
Infectious Diseases Research, National Institutes of Health, HHS)

    Dated: February 24, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
 [FR Doc. E9-4411 Filed 3-2-09; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Exhibit 32.1

WRITTEN STATEMENT

PURSUANT TO

18 U.S.C. SECTION 1350

The undersigned, James V. Mazzo and Richard A. Meier, the Chief Executive Officer
and the Principal Financial Officer, respectively, of Advanced Medical Optics, Inc. (the Company), pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. §1350, hereby certify to the best of their knowledge that:

(i) the Quarterly Report on Form 10-Q/A of the Company for the quarterly period ended September 28, 2007 (the
Report) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 780(d)); and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
of the Company.

Dated: November 8, 2007



/s/ James V. MazzoJames V. Mazzo,Chairman of the Board, President and Chief Executive Officer/s/ Richard A. MeierRichard A. Meier,Chief Operating Officer (Principal Financial Officer)


A signed original of this written statement required by Section 906 has been provided to Advanced
Medical Optics, Inc. and will be retained by Advanced Medical Optics, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
PHG ASHEVILLE, LLC v. CITY OF ASHEVILLE

No. 434PA18

Supreme Court of North Carolina.

May 9, 2019

Catherine A. Hofmann, Assistant City Attorney, Robin Tatum Currin, City Attorney, Andrew H. Erteschik, Chad W. Essick, Colin R. McGrath, N. Cosmo Zinkow, Attorneys at Law, Raleigh, For City Of Asheville.

Thomas E. Terrell, Jr., Kip David Nelson, Attorneys at Law, Greensboro, For PHG Asheville, LLC.

***ORDER***

Upon consideration of the petition filed on the 11th of December 2018 by Respondent in this matter for discretionary review of the decision of the North Carolina Court of Appeals pursuant to G.S. 7A-31, the following order was entered and is hereby certified to the North Carolina Court of Appeals:

"Allowed by order of the Court in conference, this the 9th of May 2019."

Therefore the case is docketed as of the date of this order's certification. Briefs of the respective parties shall be submitted to this Court within the times allowed and in the manner provided by Appellate Rule 15(g)(2).
Amendment No. 2011-1  Executive Involuntary Deferred Compensation Plan



 Exhibit 10.12.1 
 Exhibit B 
 Resolution No. Res.-01 

SUNOCO, INC. 
 EXECUTIVE INVOLUNTARY DEFERRED COMPENSATION PLAN 
 Amendment
No. 2011-1 
  

	1.	New Section 2.3 is added , as follows, effective January 1, 2011: 

 “2.3 Transition from Deferral Requirement. Notwithstanding the foregoing, Article II in its entirety is effective only with respect to the Performance Year ended December 31, 2010, and
after all deferrals are paid or forfeited with respect to such Performance Year, such Article II shall be deleted and of no further force and effect.
**EXHIBIT      32.1**

**CERTIFICATION      PURSUANT TO**

**18      U.S.C. SECTION 1350,**

**AS      ADOPTED PURSUANT TO**

**SECTION      906 OF THE SARBANES-OXLEY ACT OF 2002**

| 1. | The                Report fully complies with the requirements of Section 13(a) or 15(d)                of                the Securities Exchange Act of 1934;                and |
|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2. | The                information contained in the Report fairly presents, in all material                respects, the financial condition and results of operations of the                Company. |
|----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   |                                                                            |                           |
|--------|---------------------------------------------------------------------------------|--------------------------------|
|        |                                                                                 | /s/              DANIEL ZWIREN |
|   | Daniel              Zwiren                                                      |
|   | President                and                Chief Executive OfficerMay 21, 2007 |

----
Exhibit 32.1


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Tornado Gold International Corp. (the
"Company") on Form 10-QSB for the quarter ending June 30, 2004 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Earl W.
Abbott, Chief Executive Officer and Chief Financial Officer of the Company,
hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

       (1)  The report fully complies with the requirements of Section 13(a) or
            15(d) of the Securities Exchange Act of 1934; and

       (2)  The information contained in the Report fairly presents, in all
            material respects, the financial condition and results of
            operations of the Company.



August 13, 2004              By: /s/ Earl W. Abbott
                                ---------------------------------------
                                 Earl W. Abbott
                                 Chief Executive Officer and Chief
                                 Financial Officer
Unassociated Document









Exhibit 10.4




 


LOAN AGREEMENT


(Unsecured)







This Agreement, by and between Imobolis, Inc. a corporation duly organized and existing under the laws of the State of Nevada, "Corporation" and, Julian Spitari an individual "Note Holder".







WITNESSETH:


WHEREAS, Note Holder is willing to lend Imobolis, Inc. the aggregate sum of $1,804 which shall be evidenced by this executed Short term note.


The key terms and conditions are detailed below.


The funds are too be used for working capital of Imobolis, Inc.


The other key terms and conditions of the loan facility are as follows:







Borrower:


Imobolis, Inc.


8950 West Olympic Blvd.  Suite 350,


Beverly Hills, CA 90211


 


 


Note Holder: Julian Spitari


Amount of loan: $1,804


Term: Due on Demand


Rate: 8% annual interest will be accrued on note until re-payment.


Conversion: There are no conversion rights.







 


 


Execution and Date:


 


By:____Julian Spitari, President of Imobolis, Inc.


  /s/       Julian Spitari                                                 


Printed Name: Julian Spitari                                    


Date: November 16, 2010
DENT

Table IV, Insignificant defect – not scored. – No distortion of 

end seam. Does not materially affect the appearance or 

usability.
ex10x2.htm


Exhibit 10.2


 


 


 



FUEL TECHNOLOGY PRODUCTS, INC


3184-D Airway Avenue


Costa Mesa, California 92626


(775) 886-0601     FAX  (775) 883-2723












April 10, 2011







N O T E







This Agreement made on the 10th day of April, 2011, between Donald J. Rackemann and Fuel Technology Products, Inc.







Donald J. Rackemann agrees to loan monies to Fuel Technology Products, Inc. from time to time on an open account basis.  The money advances will be at no interest and may be repaid from time to time as funds from the company are available.







I hereby agree to this arrangement.

















Signed:  /s/Donald J. Rackemann







Approved:  /s/Willaim H. Marcel, President
**Exhibit 31.2**

**CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO**

**SECURITIES EXCHANGE ACT RULES 13a-15(e), AS ADOPTED PURSUANT**

**TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Brett White, certify that: 

1. I have reviewed this quarterly report on Form 10-Q of Meru Networks, Inc.; 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material factnecessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in allmaterial respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls andprocedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have: 

a) Designed suchdisclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to usby others within those entities, particularly during the period in which this report is being prepared; 

b) Evaluated theeffectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based onsuch evaluation; and 

c) Disclosed in this report any change in the registrant’s internal control overfinancial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, theregistrant’s internal control over financial reporting; and 

5. The registrant’s other certifying officerand I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalentfunctions): 

a) All significant deficiencies and material weaknesses in the design or operation of internal control overfinancial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in theregistrant’s internal control over financial reporting. 

 

Dated: August 6, 2010
```

[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4916 Engrossed in House (EH)]

  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
109th CONGRESS
  2d Session
                                H. R. 4916

_______________________________________________________________________

                                 AN ACT

 
 To authorize United States participation in, and appropriations for, 
   the United States contribution to the first replenishment of the 
 resources of the Enterprise for the Americas Multilateral Investment 
                                 Fund.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. FIRST REPLENISHMENT OF THE RESOURCES OF THE ENTERPRISE FOR 
              THE AMERICAS MULTILATERAL INVESTMENT FUND.

    The Inter-American Development Bank Act (22 U.S.C. 283 et seq.) is 
amended by adding at the end the following:

``SEC. 39. FIRST REPLENISHMENT OF THE RESOURCES OF THE ENTERPRISE FOR 
              THE AMERICAS MULTILATERAL INVESTMENT FUND.

    ``(a) Contribution Authority.--
            ``(1) In general.--The Secretary of the Treasury may 
        contribute on behalf of the United States $150,000,000 to the 
        first replenishment of the resources of the Enterprise for the 
        Americas Multilateral Investment Fund.
            ``(2) Subject to appropriations.--The authority provided by 
        paragraph (1) may be exercised only to the extent and in the 
        amounts provided for in advance in appropriations Acts.
    ``(b) Limitations on Authorization of Appropriations.--For the 
United States contribution authorized by subsection (a), there are 
authorized to be appropriated not more than $150,000,000, without 
fiscal year limitation, for payment by the Secretary of the 
Treasury.''.

            Passed the House of Representatives April 25, 2006.

            Attest:

                                                                 Clerk.
109th CONGRESS

  2d Session

                               H. R. 4916

_______________________________________________________________________

                                 AN ACT

 To authorize United States participation in, and appropriations for, 
   the United States contribution to the first replenishment of the 
 resources of the Enterprise for the Americas Multilateral Investment 
                                 Fund.
```
#### In the Matter of Randy Campney, Appellant, v The People of the State of New York, Respondent.

[718 NYS2d 898]

Mercure, J.

Appeal from an order of the County Court of Washington County (Berke, J.), entered November 24, 1999, which denied petitioner’s application pursuant to CPL 390.50 for a copy of his presentence report.

Petitioner applied to obtain a copy of the presentence report prepared in a criminal action against him which resulted in a judgment of conviction imposing an indeterminate term of imprisonment. Recognizing that, after final judgment in a criminal action, a defendant may obtain a copy of his or her presentence report in a collateral proceeding upon a proper showing of need (see, *e.g., Matter of Blanche v People,*193 AD2d 991), County Court examined petitioner’s application and concluded that petitioner had failed to make the requisite showing. Petitioner appeals and we affirm. The need for the report alleged by petitioner is based upon his claim that he is planning to apply for certain prison programs and future parole release consideration, a claim which is speculative and insufficient to support petitioner’s application *(see, Matter of Kilgore v People,*274 AD2d 636).

Cardona, P. J., Crew III, Peters and Rose, JJ., concur. Ordered that the order is affirmed, without costs.
STATE of North Carolina v. William Sakon PARKER

No. 396P18

Supreme Court of North Carolina.

March 27, 2019

Michael E. Casterline, Attorney at Law, William Sakon Parker, for Parker, William Sakon.

Marie Hartwell Evitt, Attorney at Law, Daniel P. O'Brien, Special Deputy Attorney General, N. Lorrin Freeman, District Attorney, for State of North Carolina.

Upon consideration of the petition filed on the 6th of November 2018 by Defendant in this matter for discretionary review of the decision of the North Carolina Court of Appeals pursuant to G.S. 7A-31, the following order was entered and is hereby certified to the North Carolina Court of Appeals:

*409"Denied by order of the Court in conference, this the 27th of March 2019."

Morgan, J. recused
Copy °Pt STEVE MDSE R X0.23 

FISH RETURN SYSTEM OPTIMIZATION STUDY: 

SUMMARY OF RESULTS AND DISCUSSION, 

CONSIDERATIONS, AND RECOMMENDATIONS 

FINAL REPORT 

JACKSONVILLE ELECTRIC AUTHORITY 

NORTHSIDE GENERATING STATION 

Prepared For: 

Jacksonville Electric Authority 

Jacksonville, Florida 

Prepared By: 

Mark Mossier 

Golder Associates Inc. 

6241 NW 23rd Street, Suite 500 

Gainesville, Florida 32653-1500 

October 1999 

9837517B/R6 

DISTRIBUTION: 

5 Copies - JEA 

1 Copy - Golder Associates Inc.
This disposition is not appropriate for publication and is not precedent *

except as provided by 9th Cir. R. 36-3.

The panel unanimously concludes this case is suitable for decision **

without oral argument. See Fed. R. App. P. 34(a)(2).

NOT FOR PUBLICATION

UNITED STATES COURT OF APPEALS

 FOR THE NINTH CIRCUIT

DAVID P. VANDAMENT,

 Plaintiff - Appellant,

 v.

MARK DUNCAN, Commander; et al.,

 Defendants - Appellees.

No. 08-35973

D.C. No. 3:08-cv-05522-RJB

MEMORANDUM*

Appeal from the United States District Court

for the Western District of Washington

Robert J. Bryan, District Judge, Presiding

Submitted October 19, 2010** 

Before: O’SCANNLAIN, TALLMAN, and BEA, Circuit Judges.

David P. Vandament, a Washington state prisoner, appeals pro se from the

district court’s judgment dismissing without prejudice his 42 U.S.C. § 1983 action. 

We have jurisdiction under 28 U.S.C. § 1291. We review de novo a dismissal

FILED

OCT 29 2010

MOLLY C. DWYER, CLERK

U.S. COURT OF APPEALS
2 08-35973

under 28 U.S.C. § 1915(e)(2), Huftile v. Miccio-Fonseca, 410 F.3d 1136, 1138 (9th

Cir. 2005), and may affirm on any ground supported by the record, O’Guinn v.

Lovelock Corr. Ctr., 502 F.3d 1056, 1059 (9th Cir. 2007). We affirm.

The district court properly dismissed without prejudice Vandament’s claims

based on arrests, searches and seizure. See Harvey v. Waldron, 210 F.3d 1008,

1013 (9th Cir. 2000), overruled on other grounds by Wallace v. Kato, 549 U.S. 384

(2007) (“a § 1983 action that would call into question the lawfulness of a

plaintiff’s conviction or confinement is not cognizable” under Heck v. Humphrey,

512 U.S. 477 (1994)). Because amendment would be futile, the district court

properly dismissed these claims without leave to amend. See Cato v. United

States, 70 F.3d 1103, 1106 (9th Cir. 1995). We are not persuaded that any

remaining claims are cognizable or could be cured by amendment. See id.

We do not consider arguments raised for the first time on appeal. See Smith

v. Marsh, 194 F.3d 1045, 1052 (9th Cir. 1999).

AFFIRMED.
Exhibit
32.1





CERTIFICATE
OF CHIEF EXECUTIVE OFFICER


PURSUANT
TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


(18
U.S.C. 1350)





The
undersigned, Julian R. Geiger has executed this certificate in connection with
the filing with the Securities and Exchange Commission of the Company’s report
on Form 10-Q for the quarterly period ended November 1, 2008 (the
“Report”).





The
undersigned hereby certifies that to his knowledge:





1. The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities and Exchange Act of 1934, as amended (the “Exchange Act”);
and





2. The
information contained in this Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.





IN
WITNESS WHEREOF, the undersigned has executed this certification as of the 9th
day of December 2008.





/s/
      JULIAN R. GEIGERJulian
      R. GeigerChairman
      of the Board and Chief Executive Officer(Principal
      Executive Officer)





This
certification accompanies the Report pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the
Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of
Section 18 of the Exchange Act. A signed original of this written statement
required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to
the Company and will be retained by the Company and furnished to the Securities
and Exchange Commission or its staff upon request.


30
IN RE: Tony OXENDINE

No. 424P18

Supreme Court of North Carolina.

May 9, 2019

Daniel P. O'Brien, Special Deputy Attorney General, Ben R. David, District Attorney, for State of North Carolina.

Tony Oxendine, for Oxendine, Tony.

***ORDER***

Upon consideration of the petition filed by Petitioner on the 30th of November 2018 in this matter for a writ of mandamus, the following order was entered and is hereby certified to the Superior Court, Pender County:

"Denied by order of the Court in conference, this the 9th of May 2019."